The latest health news covers the European Medicines Agency supporting Novo Nordisk’s drug for heart failure in obese ...

The European Commission on Friday extended the authorization of the Imvanex mpox vaccine to teenagers aged 12 to 17.

Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for an update of Novo Nordisk A/S’ (NYSE ...

Among other movers, Novo Nordisk advanced 0.5% after the European Medicines Agency backed the use of the Danish drugmaker’s ...

Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and ...

Committee for Human Medicinal Products (CHMP) recommended approval of five novel medicines at its September meeting ...

EMA’s human medicines committee elects Bruno Sepodes as new chair: Amsterdam, The Netherlands Friday, September 20, 2024, ...

Merck & Co. said a European Medicines Agency panel recommended expanded approval of the drugmaker's blockbuster cancer treatment Keytruda in two types of gynecologic cancers.

The European stock markets closed lower in Friday trading as the FTSE in London was down 1.19%, Germany's DAX slipped 1.49%, France's CAC lost 1.51%, the Stoxx Europe 600 fell 1.42% and the Swiss ...

BAGSVAERD, Denmark I 19, 2024 I Novo Nordisk today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human ...

By Shubham Batra (Reuters) -European shares slipped on Friday after a rally in the previous session spurred by the U.S.

Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and older Data demonstrate that the Omicron KP.2-adapted ...